Surviving the COVID-19 Pandemic: Surge Capacity Planning for Nonemergent Surgery.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has confronted the U.S. health care system with unprecedented challenges amidst a tenuous economic environment. As inpatient hospitals across the country prepare for an overwhelming influx of highly contagious COVID-19 cases, many nonemergent procedures have been cancelled or indefinitely postponed without guidance regarding eventual safe accommodation of these procedures in the future. Given the potentially prolonged impact of the COVID-19 pandemic on health care use, it is imperative for plastic surgeons to collaborate with other medical and surgical specialties to develop surge capacity protocols that allow continuation of safe, high-quality, nonemergent procedures. The purpose of this article is to provide necessary and timely public health information relevant to plastic surgery and also share a conceptual framework to guide surge capacity protocols for nonemergent surgery.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 약물 | COVID-19
→ coronavirus disease 2019
|
scispacy | 1 | ||
| 질환 | coronavirus disease 2019
|
C5203670
COVID19 (disease)
|
scispacy | 1 | |
| 기타 | coronavirus disease 2019
|
scispacy | 1 |
MeSH Terms
Ambulatory Surgical Procedures; Betacoronavirus; COVID-19; Coronavirus Infections; Elective Surgical Procedures; Humans; Infection Control; Intersectoral Collaboration; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Plastic Surgery Procedures; Regional Health Planning; SARS-CoV-2; Surge Capacity; Surgery, Plastic; Surgicenters; Telemedicine; United States